H. Karahashi et al., A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1, BBA-MOL BAS, 1502(2), 2000, pp. 207-223
Citations number
39
Categorie Soggetti
Medical Research General Topics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
A selective p38 MAP kinase (p38 MAPK) inhibitor, SB202190, induced apoptoti
c cell death of a macrophagelike cell line, J774.1, in the presence of lipo
polysaccharide (LPS), as judged by DNA nicks revealed by terminal deoxy tra
nsferase (TdT)-mediated dUTP nick end labeling (TUNEL), activation of caspa
se-3, and subsequent release of lactate dehydrogenase. This cytotoxicity wa
s dependent on both LPS and SB202190, and such inhibitors of the upstream L
PS-signaling cascade as polymyxin B and TPCK blocked this macrophage cell d
eath. SB202190 suppressed the kinase activity of p38, leading to inhibition
of activation of MAPKAPK2 and then the subsequent phosphorylation of hsp27
in LPS-treated macrophages both in vitro and in vivo, but an inactive anal
og of SB202190, SB202474, did not. There was a threshold of the time of add
ition of SB202190 to LPS-treated macrophages to induce apoptosis, which was
before full transmission of p38 activity to a direct downstream kinase, MA
PKAPK2. Besides, localization of phosphorylated hsp27 in Golgi area of the
LPS-treated macrophages was suppressed by SB202190, while it was not by SB2
02474. These results suggest that selective inhibition of p38 MAPK activity
in LPS-induced MAP kinase cascade leads to apoptosis of macrophages. (C) 2
000 Elsevier Science B.V. All rights reserved.